AMSTERDAM and TAIPEI, Taiwan, Oct.
13, 2017 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX:
PHIA), a global leader in health technology, today announced it has
received 510(k) clearance from the U.S. Food and Drug
Administration (FDA) to market the new eL18-4 transducer with full
solution for 'small parts' assessment, which is an ultrasound exam
to detect abnormalities in the small organs that are close to the
skin. The Philips Ultimate Small Parts Solution features four key
innovations that work together to help improve patient care: the
eL18-4 PureWave linear array transducer, Philips MicroFlow Imaging,
Philips Elastography and Philips Precision Biopsy. The new eL18-4
transducer can also be used to assess musculoskeletal injuries.
Philips will debut this latest solution, which is available
on Philips EPIQ 7 and 5 and Affiniti 70 ultrasound systems, at the
16th World Federation for Ultrasound in Medicine and
Biology (WFUMB) Congress in Taipei.
A vital tool for improving patient care, small parts imaging is
a rapidly growing segment of ultrasound examinations for clinicians
around the world. Its broad set of applications include assessment
of diseases and disorders of small organs such as breasts,
testicles and thyroid, as well as musculoskeletal injuries like
sprains and tears. High-resolution ultrasound, such as that
available on Philips EPIQ and Affiniti solutions, allows clinicians
to visualize and characterize abnormalities and evaluate organ
blood flow, guide treatment and perform biopsies of suspicious
lesions.
"The superb image quality derived from Philips' breakthrough,
ultra-broadband frequency transducer along with full solution
Elastography support, helps clinicians make confident clinical
decisions driven by an exam that is easier to perform," said
Vitor Rocha, Ultrasound Business
Leader at Philips. "With the new Philips Ultimate Small Parts
Solution, clinicians now have the power to comprehensively assess
and treat small parts and deliver better care for their patients
with all-in-one functionality."
"My clinical experience with the new Philips eL18-4 small parts
transducer has enabled excellent versatility and penetration that
could easily replace my current transducers," said Dr. Lynwood Hammers, Hammer Imaging, New Haven,
CT. "I am able to see subtle lesions with great detail and
excellent sensitivity for small vessel details. In my opinion, this
new small parts transducer definitely elevates my clinical
confidence and decreases indeterminate diagnosis."
New Capabilities Advance Confident
Diagnoses
The Philips EPIQ Ultimate Small Parts Solution is comprised of a
suite of features for small parts assessment. These include:
- The Philips eL18-4 transducer, allows fine-elevation
focusing to deliver exceptional detail resolution and tissue
uniformity for clinical solutions, including: thyroid, breast,
testicular, musculoskeletal, vascular, bowel, pediatrics and
obstetrics.
- Philips MicroFlow Imaging, provides remarkable
sensitivity and detail for small vessel blood flow assessment.
- Complete Elastography solution with both strain and
ElastQ Imaging shear wave capability, reveals definitive
information on tissue stiffness.
- New precision biopsy capabilities, help minimize needle
blind zones and support the ability to enhance the display of
needle reflections – all to elevate confidence during
interventional procedures.
Delivering Exceptional Care with Ultrasound
This eL18-4 small parts solution builds upon both the EPIQ and
Affiniti platforms, enabling radiologists to have more confidence
in their diagnosis, maximize productivity and connected workflow,
and facilitate patient data security with best-in-class imaging
solutions that fit clinicians' unique needs. Together, EPIQ and
Affiniti deliver on Philips' commitment to improving patient care
with industry-leading solutions.
Philips is a leader in cardiac ultrasound imaging, disease
specific applications and services. The company is expanding its
portfolio in OB/GYN, point-of-care and general imaging. For more
information on Philips' general imaging ultrasound portfolio visit
http://philips.to/2jPsYWq. Stop by the Philips booth E2 at WFUMB
2017, in Taipei, Taiwan, from
October 13-17, to experience its
latest advancements in general imaging ultrasound, and follow
@PhilipsLiveFrom for updates throughout the congress.
For further information, please contact:
Alicia Cafardi
Philips Group Press Office
Mobile: +1 412 523 9616
Email: Alicia.Cafardi@philips.com
Twitter: @aliciacafardi
Sarah Haeger
Philips Ultrasound
Mobile: +1 206-920-8726
Email: Sarah.Haeger@philips.com
Twitter: @sarahhaeger
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA)
is a leading health technology company focused on improving
people's health and enabling better outcomes across the health
continuum from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips' health
technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 71,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
View original content with
multimedia:http://www.prnewswire.com/news-releases/philips-receives-us-fda-510k-clearance-to-market-its-solution-for-small-parts-ultrasound-imaging-300536399.html
SOURCE Royal Philips